Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Dog Vaccines Market Growth 2022-2028

  • LP 4920735
  • 105 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Dog Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Dog Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Dog Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Dog Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dog Vaccines market, reaching US$ million by the year 2028. As for the Europe Dog Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Dog Vaccines players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Dog Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Below 6 Months

Above Months

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer Healthcare

Vetoquinol S.A

Boehringer Ingelheim

Ceva

Eli Lilly

Heska Co.

Merck Animal Health

Merial (Sanofi)

Virbac

Zoetis (Pfizer)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dog Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Dog Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Dog Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Dog Vaccines Segment by Type

2.2.1 Attenuated Live Vaccines

2.2.2 Conjugate Vaccines

2.2.3 Inactivated Vaccines

2.2.4 Subunit Vaccines

2.2.5 Toxoid Vaccines

2.2.6 DNA Vaccines

2.2.7 Recombinant Vaccines

2.3 Dog Vaccines Sales by Type

2.3.1 Global Dog Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Dog Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Dog Vaccines Sale Price by Type (2017-2022)

2.4 Dog Vaccines Segment by Application

2.4.1 Below 6 Months

2.4.2 Above Months

2.5 Dog Vaccines Sales by Application

2.5.1 Global Dog Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Dog Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Dog Vaccines Sale Price by Application (2017-2022)

3 Global Dog Vaccines by Company

3.1 Global Dog Vaccines Breakdown Data by Company

3.1.1 Global Dog Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Dog Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Dog Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Dog Vaccines Revenue by Company (2020-2022)

3.2.2 Global Dog Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Dog Vaccines Sale Price by Company

3.4 Key Manufacturers Dog Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dog Vaccines Product Location Distribution

3.4.2 Players Dog Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Dog Vaccines by Geographic Region

4.1 World Historic Dog Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Dog Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Dog Vaccines Annual Revenue by Geographic Region

4.2 World Historic Dog Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Dog Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Dog Vaccines Annual Revenue by Country/Region

4.3 Americas Dog Vaccines Sales Growth

4.4 APAC Dog Vaccines Sales Growth

4.5 Europe Dog Vaccines Sales Growth

4.6 Middle East & Africa Dog Vaccines Sales Growth

5 Americas

5.1 Americas Dog Vaccines Sales by Country

5.1.1 Americas Dog Vaccines Sales by Country (2017-2022)

5.1.2 Americas Dog Vaccines Revenue by Country (2017-2022)

5.2 Americas Dog Vaccines Sales by Type

5.3 Americas Dog Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dog Vaccines Sales by Region

6.1.1 APAC Dog Vaccines Sales by Region (2017-2022)

6.1.2 APAC Dog Vaccines Revenue by Region (2017-2022)

6.2 APAC Dog Vaccines Sales by Type

6.3 APAC Dog Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Dog Vaccines by Country

7.1.1 Europe Dog Vaccines Sales by Country (2017-2022)

7.1.2 Europe Dog Vaccines Revenue by Country (2017-2022)

7.2 Europe Dog Vaccines Sales by Type

7.3 Europe Dog Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dog Vaccines by Country

8.1.1 Middle East & Africa Dog Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Dog Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Dog Vaccines Sales by Type

8.3 Middle East & Africa Dog Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Dog Vaccines

10.3 Manufacturing Process Analysis of Dog Vaccines

10.4 Industry Chain Structure of Dog Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Dog Vaccines Distributors

11.3 Dog Vaccines Customer

12 World Forecast Review for Dog Vaccines by Geographic Region

12.1 Global Dog Vaccines Market Size Forecast by Region

12.1.1 Global Dog Vaccines Forecast by Region (2023-2028)

12.1.2 Global Dog Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Dog Vaccines Forecast by Type

12.7 Global Dog Vaccines Forecast by Application

13 Key Players Analysis

13.1 Bayer Healthcare

13.1.1 Bayer Healthcare Company Information

13.1.2 Bayer Healthcare Dog Vaccines Product Offered

13.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Healthcare Main Business Overview

13.1.5 Bayer Healthcare Latest Developments

13.2 Vetoquinol S.A

13.2.1 Vetoquinol S.A Company Information

13.2.2 Vetoquinol S.A Dog Vaccines Product Offered

13.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Vetoquinol S.A Main Business Overview

13.2.5 Vetoquinol S.A Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Dog Vaccines Product Offered

13.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva

13.4.1 Ceva Company Information

13.4.2 Ceva Dog Vaccines Product Offered

13.4.3 Ceva Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Main Business Overview

13.4.5 Ceva Latest Developments

13.5 Eli Lilly

13.5.1 Eli Lilly Company Information

13.5.2 Eli Lilly Dog Vaccines Product Offered

13.5.3 Eli Lilly Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly Main Business Overview

13.5.5 Eli Lilly Latest Developments

13.6 Heska Co.

13.6.1 Heska Co. Company Information

13.6.2 Heska Co. Dog Vaccines Product Offered

13.6.3 Heska Co. Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Heska Co. Main Business Overview

13.6.5 Heska Co. Latest Developments

13.7 Merck Animal Health

13.7.1 Merck Animal Health Company Information

13.7.2 Merck Animal Health Dog Vaccines Product Offered

13.7.3 Merck Animal Health Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Animal Health Main Business Overview

13.7.5 Merck Animal Health Latest Developments

13.8 Merial (Sanofi)

13.8.1 Merial (Sanofi) Company Information

13.8.2 Merial (Sanofi) Dog Vaccines Product Offered

13.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merial (Sanofi) Main Business Overview

13.8.5 Merial (Sanofi) Latest Developments

13.9 Virbac

13.9.1 Virbac Company Information

13.9.2 Virbac Dog Vaccines Product Offered

13.9.3 Virbac Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Virbac Main Business Overview

13.9.5 Virbac Latest Developments

13.10 Zoetis (Pfizer)

13.10.1 Zoetis (Pfizer) Company Information

13.10.2 Zoetis (Pfizer) Dog Vaccines Product Offered

13.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Zoetis (Pfizer) Main Business Overview

13.10.5 Zoetis (Pfizer) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Dog Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Dog Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Attenuated Live Vaccines

Table 4. Major Players of Conjugate Vaccines

Table 5. Major Players of Inactivated Vaccines

Table 6. Major Players of Subunit Vaccines

Table 7. Major Players of Toxoid Vaccines

Table 8. Major Players of DNA Vaccines

Table 9. Major Players of Recombinant Vaccines

Table 10. Global Dog Vaccines Sales by Type (2017-2022) & (K Doses)

Table 11. Global Dog Vaccines Sales Market Share by Type (2017-2022)

Table 12. Global Dog Vaccines Revenue by Type (2017-2022) & ($ million)

Table 13. Global Dog Vaccines Revenue Market Share by Type (2017-2022)

Table 14. Global Dog Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 15. Global Dog Vaccines Sales by Application (2017-2022) & (K Doses)

Table 16. Global Dog Vaccines Sales Market Share by Application (2017-2022)

Table 17. Global Dog Vaccines Revenue by Application (2017-2022)

Table 18. Global Dog Vaccines Revenue Market Share by Application (2017-2022)

Table 19. Global Dog Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 20. Global Dog Vaccines Sales by Company (2020-2022) & (K Doses)

Table 21. Global Dog Vaccines Sales Market Share by Company (2020-2022)

Table 22. Global Dog Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Dog Vaccines Revenue Market Share by Company (2020-2022)

Table 24. Global Dog Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 25. Key Manufacturers Dog Vaccines Producing Area Distribution and Sales Area

Table 26. Players Dog Vaccines Products Offered

Table 27. Dog Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Dog Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 31. Global Dog Vaccines Sales Market Share Geographic Region (2017-2022)

Table 32. Global Dog Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Dog Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Dog Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 35. Global Dog Vaccines Sales Market Share by Country/Region (2017-2022)

Table 36. Global Dog Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Dog Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Dog Vaccines Sales by Country (2017-2022) & (K Doses)

Table 39. Americas Dog Vaccines Sales Market Share by Country (2017-2022)

Table 40. Americas Dog Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Dog Vaccines Revenue Market Share by Country (2017-2022)

Table 42. Americas Dog Vaccines Sales by Type (2017-2022) & (K Doses)

Table 43. Americas Dog Vaccines Sales Market Share by Type (2017-2022)

Table 44. Americas Dog Vaccines Sales by Application (2017-2022) & (K Doses)

Table 45. Americas Dog Vaccines Sales Market Share by Application (2017-2022)

Table 46. APAC Dog Vaccines Sales by Region (2017-2022) & (K Doses)

Table 47. APAC Dog Vaccines Sales Market Share by Region (2017-2022)

Table 48. APAC Dog Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Dog Vaccines Revenue Market Share by Region (2017-2022)

Table 50. APAC Dog Vaccines Sales by Type (2017-2022) & (K Doses)

Table 51. APAC Dog Vaccines Sales Market Share by Type (2017-2022)

Table 52. APAC Dog Vaccines Sales by Application (2017-2022) & (K Doses)

Table 53. APAC Dog Vaccines Sales Market Share by Application (2017-2022)

Table 54. Europe Dog Vaccines Sales by Country (2017-2022) & (K Doses)

Table 55. Europe Dog Vaccines Sales Market Share by Country (2017-2022)

Table 56. Europe Dog Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Dog Vaccines Revenue Market Share by Country (2017-2022)

Table 58. Europe Dog Vaccines Sales by Type (2017-2022) & (K Doses)

Table 59. Europe Dog Vaccines Sales Market Share by Type (2017-2022)

Table 60. Europe Dog Vaccines Sales by Application (2017-2022) & (K Doses)

Table 61. Europe Dog Vaccines Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Dog Vaccines Sales by Country (2017-2022) & (K Doses)

Table 63. Middle East & Africa Dog Vaccines Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Dog Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Dog Vaccines Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Dog Vaccines Sales by Type (2017-2022) & (K Doses)

Table 67. Middle East & Africa Dog Vaccines Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Dog Vaccines Sales by Application (2017-2022) & (K Doses)

Table 69. Middle East & Africa Dog Vaccines Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Dog Vaccines

Table 71. Key Market Challenges & Risks of Dog Vaccines

Table 72. Key Industry Trends of Dog Vaccines

Table 73. Dog Vaccines Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Dog Vaccines Distributors List

Table 76. Dog Vaccines Customer List

Table 77. Global Dog Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 78. Global Dog Vaccines Sales Market Forecast by Region

Table 79. Global Dog Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Dog Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Dog Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Americas Dog Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Dog Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 84. APAC Dog Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Dog Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 86. Europe Dog Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Dog Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 88. Middle East & Africa Dog Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Dog Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 90. Global Dog Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Dog Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Dog Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Dog Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 94. Global Dog Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Dog Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Dog Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 97. Bayer Healthcare Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer Healthcare Dog Vaccines Product Offered

Table 99. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 100. Bayer Healthcare Main Business

Table 101. Bayer Healthcare Latest Developments

Table 102. Vetoquinol S.A Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Vetoquinol S.A Dog Vaccines Product Offered

Table 104. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 105. Vetoquinol S.A Main Business

Table 106. Vetoquinol S.A Latest Developments

Table 107. Boehringer Ingelheim Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Boehringer Ingelheim Dog Vaccines Product Offered

Table 109. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 110. Boehringer Ingelheim Main Business

Table 111. Boehringer Ingelheim Latest Developments

Table 112. Ceva Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Ceva Dog Vaccines Product Offered

Table 114. Ceva Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 115. Ceva Main Business

Table 116. Ceva Latest Developments

Table 117. Eli Lilly Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Eli Lilly Dog Vaccines Product Offered

Table 119. Eli Lilly Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 120. Eli Lilly Main Business

Table 121. Eli Lilly Latest Developments

Table 122. Heska Co. Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Heska Co. Dog Vaccines Product Offered

Table 124. Heska Co. Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 125. Heska Co. Main Business

Table 126. Heska Co. Latest Developments

Table 127. Merck Animal Health Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Merck Animal Health Dog Vaccines Product Offered

Table 129. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 130. Merck Animal Health Main Business

Table 131. Merck Animal Health Latest Developments

Table 132. Merial (Sanofi) Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Merial (Sanofi) Dog Vaccines Product Offered

Table 134. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 135. Merial (Sanofi) Main Business

Table 136. Merial (Sanofi) Latest Developments

Table 137. Virbac Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Virbac Dog Vaccines Product Offered

Table 139. Virbac Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 140. Virbac Main Business

Table 141. Virbac Latest Developments

Table 142. Zoetis (Pfizer) Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Zoetis (Pfizer) Dog Vaccines Product Offered

Table 144. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 145. Zoetis (Pfizer) Main Business

Table 146. Zoetis (Pfizer) Latest Developments

List of Figures

Figure 1. Picture of Dog Vaccines

Figure 2. Dog Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dog Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Dog Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Dog Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Attenuated Live Vaccines

Figure 10. Product Picture of Conjugate Vaccines

Figure 11. Product Picture of Inactivated Vaccines

Figure 12. Product Picture of Subunit Vaccines

Figure 13. Product Picture of Toxoid Vaccines

Figure 14. Product Picture of DNA Vaccines

Figure 15. Product Picture of Recombinant Vaccines

Figure 16. Global Dog Vaccines Sales Market Share by Type in 2021

Figure 17. Global Dog Vaccines Revenue Market Share by Type (2017-2022)

Figure 18. Dog Vaccines Consumed in Below 6 Months

Figure 19. Global Dog Vaccines Market: Below 6 Months (2017-2022) & (K Doses)

Figure 20. Dog Vaccines Consumed in Above Months

Figure 21. Global Dog Vaccines Market: Above Months (2017-2022) & (K Doses)

Figure 22. Global Dog Vaccines Sales Market Share by Application (2017-2022)

Figure 23. Global Dog Vaccines Revenue Market Share by Application in 2021

Figure 24. Dog Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Dog Vaccines Revenue Market Share by Company in 2021

Figure 26. Global Dog Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Dog Vaccines Revenue Market Share by Geographic Region in 2021

Figure 28. Global Dog Vaccines Sales Market Share by Region (2017-2022)

Figure 29. Global Dog Vaccines Revenue Market Share by Country/Region in 2021

Figure 30. Americas Dog Vaccines Sales 2017-2022 (K Doses)

Figure 31. Americas Dog Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. APAC Dog Vaccines Sales 2017-2022 (K Doses)

Figure 33. APAC Dog Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Europe Dog Vaccines Sales 2017-2022 (K Doses)

Figure 35. Europe Dog Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Dog Vaccines Sales 2017-2022 (K Doses)

Figure 37. Middle East & Africa Dog Vaccines Revenue 2017-2022 ($ Millions)

Figure 38. Americas Dog Vaccines Sales Market Share by Country in 2021

Figure 39. Americas Dog Vaccines Revenue Market Share by Country in 2021

Figure 40. United States Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Dog Vaccines Sales Market Share by Region in 2021

Figure 45. APAC Dog Vaccines Revenue Market Share by Regions in 2021

Figure 46. China Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Dog Vaccines Sales Market Share by Country in 2021

Figure 53. Europe Dog Vaccines Revenue Market Share by Country in 2021

Figure 54. Germany Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Dog Vaccines Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Dog Vaccines Revenue Market Share by Country in 2021

Figure 61. Egypt Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Dog Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Dog Vaccines in 2021

Figure 67. Manufacturing Process Analysis of Dog Vaccines

Figure 68. Industry Chain Structure of Dog Vaccines

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390